As Honda CR-V leads U.S. sales, automaker teases new American-built pickup truck

Honda confirmed its next-generation Ridgeline will be produced in the U.S., but a temporary production stoppage is planned later this year at its Alabama plant, with assembly resuming within two years (likely in 2028). The pause follows emissions-regulation uncertainty in California, and the company cited a shift toward greater “ruggedness” and capability to support loyal customers. Ridgeline sales were down about 3% in the first half of the year, versus ~41,000–52,000 units annually since 2021, while the CR-V led U.S. sales through H1 for the first time.

Analysis

The key market mechanism is not the temporary pause itself, but the risk that Honda is forced to spend the next 18-24 months re-engineering a low-volume nameplate just to stay compliant and relevant. That is usually margin-negative in the near term: lost dealer allocation, incremental incentive spend to protect loyalty, and some plant under-absorption if the interruption runs longer than expected. Still, the absolute earnings impact is likely modest because the truck is too small to move consolidated results by itself, so any large selloff would be more about fear of product execution than near-term P&L.

The more important second-order effect is competitive repositioning. If Honda moves the vehicle toward a more traditional truck architecture, it is implicitly conceding that the current value proposition is not enough versus true truck incumbents. That creates a window for Toyota, Ford, GM, and Stellantis to defend midsize share while Honda resets; the winners are the brands with authentic truck credibility and deeper body-on-frame operating leverage. The loser is Honda if the redesign fails to generate higher ASPs fast enough to offset the lost units.

Contrarian view: the market may be underestimating how much Honda’s crossover strength can cushion this and how small the Ridgeline actually is relative to the broader U.S. mix. The bigger long-term signal is whether Honda is willing to trade short-term volume for better product economics; if so, this could be a margin-improving portfolio decision rather than a franchise problem. What would falsify the bearish read is an earlier-than-expected restart, a clean regulatory fix, or evidence that the redesigned truck lifts annual demand materially above the current 40-50k run rate.

Key Decisions for Investors

• HMC: modest short on any relief rally over the next 1-2 sessions; thesis is execution risk and lost dealer momentum, with a downside target of ~5-7% if the market starts pricing a longer hiatus. Cover if management provides a firm restart date materially earlier than 2028 or if the next sales update shows no share loss.
• Pair trade: long TM / short HMC over 1-3 months. Toyota’s midsize truck franchise is the cleaner beneficiary if Honda is off the field, while Honda carries the re-engineering overhang. Exit if Honda confirms a faster product refresh than expected or if Tacoma inventory tightness starts reversing.
• No aggressive trade on F: the read-through to full-size truck economics is too indirect. Use F only as a watchlist name for any rare pricing spillover in midsize trucks; not a standalone catalyst.
• If HMC options liquidity is usable, favor a 3-6 month put spread rather than outright short exposure. The upside case from a future 'ruggedness' repositioning can cap downside, but the near-term risk/reward still skews to a limited multiple de-rate.